AU4565000A - Organic compounds - Google Patents

Organic compounds

Info

Publication number
AU4565000A
AU4565000A AU45650/00A AU4565000A AU4565000A AU 4565000 A AU4565000 A AU 4565000A AU 45650/00 A AU45650/00 A AU 45650/00A AU 4565000 A AU4565000 A AU 4565000A AU 4565000 A AU4565000 A AU 4565000A
Authority
AU
Australia
Prior art keywords
recipient
rejection
xenografts
pharmaceutical composition
body fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45650/00A
Other languages
English (en)
Inventor
Paolo Brenner
Emanuele Luigi Maria Cozzi
Peter John Friend
Francoise Richard
Guy Taccard
John Wallwork
David James Graham White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910835.9A external-priority patent/GB9910835D0/en
Priority claimed from GBGB9925443.5A external-priority patent/GB9925443D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU4565000A publication Critical patent/AU4565000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU45650/00A 1999-05-10 2000-05-10 Organic compounds Abandoned AU4565000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9910835 1999-05-10
GBGB9910835.9A GB9910835D0 (en) 1999-05-10 1999-05-10 Organic compounds
GBGB9925443.5A GB9925443D0 (en) 1999-10-27 1999-10-27 Organic compounds
GB9925443 1999-10-27
PCT/EP2000/004250 WO2000067773A2 (en) 1999-05-10 2000-05-10 Combinations of immunosupressive agents for the treatment or prevention of graft rejections

Publications (1)

Publication Number Publication Date
AU4565000A true AU4565000A (en) 2000-11-21

Family

ID=26315533

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45650/00A Abandoned AU4565000A (en) 1999-05-10 2000-05-10 Organic compounds

Country Status (7)

Country Link
US (5) US20020132764A1 (https=)
EP (2) EP1980263A1 (https=)
JP (1) JP2002544167A (https=)
AT (1) ATE474590T1 (https=)
AU (1) AU4565000A (https=)
DE (1) DE60044717D1 (https=)
WO (1) WO2000067773A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1208847B8 (en) * 1996-07-30 2007-02-14 Novartis AG Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
EP2298299A3 (en) 2000-01-14 2012-02-29 The Trustees Of The University Of Pennsylvania O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
CN105792775B (zh) 2013-09-24 2019-02-19 吉纳生命科学公司 用于细胞植入物的气体处理的系统
MX2019005676A (es) 2016-11-15 2019-09-10 Giner Life Sciences Inc Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo.
JP7199632B2 (ja) 2017-05-04 2023-01-06 ガイナー，インク． 堅牢なインプラント可能なガス送達装置ならびにそれを含む方法、システムおよび装置

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178858A (en) * 1987-12-02 1993-01-12 Reichert Thomas A Method for prevention of graft versus host disease
US5135934A (en) 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
AU666128B2 (en) 1991-08-23 1996-02-01 Alberta Research Council Inc. Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5843452A (en) * 1992-11-09 1998-12-01 Pharmagenesis, Inc. Immunotherapy composition and method
ES2242189T3 (es) 1994-05-13 2005-11-01 Miltenyi Biotec Gmbh Columna esteril y apirogena copulada a una proteina con miras a la fijacion y extraccion de sustancias dadas de la sangre.
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
PE52896A1 (es) 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
US5697109A (en) 1994-10-28 1997-12-16 Barton Medical Corporation Patient transport system
US5631282A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. Triterpenes
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
GB9606452D0 (en) * 1996-03-27 1996-06-05 Sandoz Ltd Organic compounds
ID18663A (id) 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
EP1208847B8 (en) * 1996-07-30 2007-02-14 Novartis AG Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
GB9619706D0 (en) 1996-09-20 1996-11-06 Pharmacia Spa Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
US5962415A (en) * 1996-09-20 1999-10-05 Bristol-Myers Squibb Co. Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
CA2284729A1 (en) 1997-04-18 1998-10-29 Novartis Ag Neoglycoproteins
AU7935598A (en) 1997-07-14 1999-02-10 Nippon Meat Packers, Inc. Transgenic mammals

Also Published As

Publication number Publication date
JP2002544167A (ja) 2002-12-24
WO2000067773A2 (en) 2000-11-16
US20050277585A1 (en) 2005-12-15
US8435520B2 (en) 2013-05-07
ATE474590T1 (de) 2010-08-15
EP1181034A2 (en) 2002-02-27
US20110142953A1 (en) 2011-06-16
WO2000067773A3 (en) 2001-06-28
US20020132764A1 (en) 2002-09-19
US20080199478A1 (en) 2008-08-21
DE60044717D1 (de) 2010-09-02
EP1181034B1 (en) 2010-07-21
US20070060511A1 (en) 2007-03-15
EP1980263A1 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
GB9917406D0 (en) Compounds
MXPA03006557A (es) METODO Y APARATO PARA REMOVER SUSTANCIAS DE LOS VASOS DEL CORAZON Y OTRAS PARTES DEL CUERPO, PARA MINIMIZAR O EVITAR DAnOS O DISFUNCIONES RENALES U OTROS.
PT1293207E (pt) Utilização de ritonavir (abt-538) para melhoria da farmacocinética de drogas metabolizadas por citocromo p450 num método de tratamento da sida
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
ES2110320T3 (es) Dispositivo de tratamiento de la superficie de carrocerias de vehiculos.
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
WO1998033491A3 (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
WO2002100148A3 (en) Treatment or prophylaxis of insulin-producing cell graft rejection
WO2002078684A3 (en) Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
AU4565000A (en) Organic compounds
BG105664A (en) Use of apomophines for the treatment of organic erectile dysfunction in males
WO2001078653A3 (en) Graft rejection inhibition with ccr2 inhibitors
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
AU8216691A (en) Autobiotics and their use in eliminating nonself cells in vivo
AU1123001A (en) Compositions and methods for preventing and treating transplant rejection
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
GB9919713D0 (en) New medical use of high density lipoprotein
EP0444899A3 (en) Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation
BG106831A (en) Compound and method for the treatment of pain
AU2202301A (en) Cd45 inhibitors
WO1995005364A3 (en) Inhibitors of biogenic amine transporters
AU1393801A (en) Method for the treatment and/or prophylaxis of diseases caused by il-12
AU2002212485A1 (en) Method and apparatus for the treatment of sludge
WO2003039231A3 (en) Compounds and methods for treating transplant rejection
AU7078298A (en) Method for the diagnosis, treatment and prophylaxis of premature ejaculation andcatheter for the diagnosis, treatment and prophylaxis of premature ejaculation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase